1 May 2023 in Current Genomics
Background: Recent studies on CRISPR/Cas9-mediated gene editing in Schistosoma mansoni have shed new light on the study and control of this parasitic helminth. However, the gene editing efficiency in this parasite is modest. Methods: To improve the efficiency of CRISPR/Cas9 genome editing in schistosomes, we used lentivirus, which has been effectively used for gene editing in mammalian cells, to deliver plasmid DNA encoding Cas9 nuclease, a sgRNA targeting acetylcholinesterase (SmAChE) and a mCherry fluorescence marker into schistosomes. Results: MCherry fluorescence was observed in transduced eggs, schistosomula, and adult worms, indicating that the CRISPR components had been delivered into these parasite stages by lentivirus. In addition, clearly changed phenotypes were observed in SmAChE-edited parasites, including decreased SmAChE activity, reduced hatching ability of edited eggs, and altered behavior of miracidia hatched from edited eggs. Next-generation sequencing analysis demonstrated that the lentiviral transductionbased CRISPR/Cas9 gene modifications in SmAChE-edited schistosomes were homology-directed repair predominant but with much lower efficiency than that obtained using electroporation (data previously published by our laboratory) for the delivery of CRISPR components. Conclusion: Taken together, electroporation is more efficient than lentiviral transduction in the delivery of CRISPR/Cas9 into schistosomes for programmed genome editing. The exploration of tactics for enhancing CRISPR/Cas9 gene editing provides the basis for the future improvement of programmed genome editing in S. mansoni.
17 August 2022 in bioRxiv
Employing the flatworm parasite Schistosoma mansoni as a model, we report the first application of CRISPR interference (CRISPRi) in parasitic helminths for loss-of-function targeting the SmfgfrA gene which encodes the stem cell marker, fibroblast growth factor receptor A. SmFGFRA is essential for maintaining schistosome stem cells and critical in the schistosome-host interplay. The SmfgfrA gene was targeted in S. mansoni adult worms, eggs and schistosomula using a catalytically dead Cas9 (dCas9) fused to a transcriptional repressor KRAB. We showed that SmfgfrA repression resulted in considerable phenotypic differences in the modulated parasites compared with controls, including reduced levels of SmfgfrA transcription and decreased protein expression of SmFGFRA, a decline in EdU (thymidine analog 5-ethynyl-2’-deoxyuridine, which specifically stains schistosome stem cells) signal, and an increase in cell apoptosis. Notably, reduced SmfgfrA transcription was evident in miracidia hatched from SmfgfrA -repressed eggs, and resulted in a significant change in miracidial behavior, indicative of a durable repression effect caused by CRISPRi. Intravenous injection of mice with SmfgfrA -repressed eggs resulted in granulomas that were markedly reduced in size and a decline in the level of serum IgE, emphasizing the importance of SmFGFRA in regulating the host immune response induced during schistosome infection. Our findings show the feasibility of applying CRISPRi for effective, targeted transcriptional repression in schistosomes, and provide the basis for employing CRISPRi to selectively perturb gene expression in parasitic helminths on a genome-wide scale.
9 March 2025 in Biocatalysis and Agricultural Biotechnology
17 September 2026 in SSRN Electronic Journal
We developed a CRISPR/dCas9-based biosensor platform for the detection of specific DNA sequences. In this biosensor, two high-fidelity (HiFi) dCas9 proteins were fused to either of the complementary NanoLuc fragments (SmBiT and LgBiT). Luminescence was generated upon colocalization of the two HiFi dCas9 fusion proteins to target sites. We applied this biosensor to detect two Y-chromosome genes in Bos taurus: multicopy TSPY (testis-specific protein, Y-encoded) and single-copy SRY (sex determining region Y). Two TSPY-sensors and one SRY-sensor were designed for gene detection. The specific DNA binding ability of the biosensor was confirmed by electrophoresis mobility shift assay and in vitro luciferase assays. TSPY-sensor1, with an interspace of 23 bp and a concentration of 20 nM, demonstrated the highest signal-to-background ratio (8-fold) in vitro. Similarly, SRY-sensor yielded 7.6-fold higher amount of luminescence than the control group in vitro. However, in cells, TSPY sensors yielded significantly higher signal-to-background ratio (8-fold) than SRY sensor (4.7-fold), suggesting a potential advantage of targeting multicopy genes for enhanced biosensor sensitivity in live-cell applications. These findings demonstrate the feasibility of using this biosensor platform for detecting specific gene sequences in vitro and in live cells.